Document Detail


Exercise training in chronic heart failure: why, when and how.
MedLine Citation:
PMID:  11727669     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The management of patients with chronic congestive heart failure has changed considerably during the last decade. Until recently, restriction of physical activity was recommended for patients with chronic heart failure. However, the knowledge that training influences largely the periphery rather than the heart itself has led to a dramatic change in the approach toward training in patients with chronic heart failure. Why to train patients with chronic heart failure: Training increases exercise tolerance by an average of 20% in chronic heart failure regardless of etiology (ischemic or non-ischemic cardiomyopathy) or severity of left ventricular dysfunction. Available data, while limited, demonstrate that increases in exercise capacity are paralleled by an improvement in quality of life. Studies have consistently demonstrated that training has no deleterious effect on central haemodynamics, left ventricular remodeling, systolic or diastolic function, or myocardial metabolism. At present, there are insufficient data to determine the effect of training on prognosis, but trials are currently underway to address this. When to train patients with chronic heart failure: Exercise training should be performed only with the patients that have been in a stable clinical condition for a period of at least 3-4 weeks. Clinical stability is defined as no change in symptoms, weight, drug regimen, or NYHA class over this period. How to train patients with chronic heart failure: Initially, the program should be supervised for a period of 2 to 4 weeks; home-based programs are usually appropriate thereafter. Activities that can be maintained for a lifetime should be encouraged, and the focus should be on aerobic-type activities. The intensity level should be targeted to about 50%-70% of peak VO2 and/or Borg ratings of 12-14 ("walk and talk").
Authors:
P Dubach; S Sixt; J Myers
Related Documents :
22201979 - Beta-adrenoceptor signaling pathways mediate cardiac pathological remodeling.
10093769 - Heart failure.
20559969 - Endoventricular electromechanical mapping-the diagnostic and therapeutic utility of the...
8668609 - Evolving concepts in the treatment of heart failure: should new inotropic agents carry ...
12783069 - Diastolic heart failure. diagnosis, prognosis, treatment.
12671339 - Growth hormone therapy in heart failure: where are we now?
9249849 - Alternating current electrocution detection and termination by an implantable cardiover...
20338359 - Sustainable myocardial recovery after mitral reconstruction for left ventricular noncom...
16302449 - Effects of total coronary artery occlusion on vascular endothieial growth factor and tr...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Swiss medical weekly     Volume:  131     ISSN:  1424-7860     ISO Abbreviation:  Swiss Med Wkly     Publication Date:  2001 Sep 
Date Detail:
Created Date:  2001-11-30     Completed Date:  2002-02-26     Revised Date:  2011-02-15    
Medline Journal Info:
Nlm Unique ID:  100970884     Medline TA:  Swiss Med Wkly     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  510-4     Citation Subset:  IM    
Affiliation:
Department of Cardiology, Kantonsspital Chur, Switzerland. Paul.Dubach@ksc.gr.ch
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Diastole
Exercise Therapy / methods*
Heart Failure / rehabilitation*
Hemodynamics / physiology*
Humans
Systole
Time Factors
Ventricular Remodeling / physiology

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hyperpolarised gases in magnetic resonance: a new tool for functional imaging of the lung.
Next Document:  Contraception and sexuality after termination of pregnancy: a comparison between Lugano and Geneva.